Articles related to SUPPORTIVE ONCOLOGY CARE

Is It Time for a New Type of Cancer Physician?

Growing numbers of cancer survivors are prompting renewed discussion about how survivorship services should be delivered, with oncology and palliative care leaders emphasizing symptom management, quality of life, clinician training, and long-term support needs.

Hematology/Oncology September 24th 2026

Tags: HEALTHCARE DELIVERY HEALTHCARE WORKFORCE PATIENT CARE PROFESSIONAL DEVELOPMENT QUALITY OF LIFE SUPPORTIVE ONCOLOGY CARE SURVIVORSHIP

MDLinx

Yale Study Finds Reduced Opioid Prescribing for Some Patients with Cancer

Opioid prescribing for cancer patients reporting no pain declined substantially across a single Connecticut health system from 2016 to 2020, while prescribing for patients reporting pain remained stable.

Medical Oncology May 26th 2026

Tags: BUSINESS & POLICY CANCER CARE OPIOIDS PAIN MANAGEMENT REAL-WORLD EVIDENCE SUPPORTIVE ONCOLOGY CARE SYMPTOM MANAGEMENT

Pharmacy Times

FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab

Comprehensive data package, including structural and functional analytical data, clinical pharmacokinetic data, and a comparative clinical study demonstrating that Bildyos and Bilprevda are highly similar to and have no clinically meaningful differences from their reference products.

Clinical Pharmacology September 3rd 2025

Tags: AMBULATORY CARE BIOSIMILARS BONE HEALTH ONCOLOGY PHARMACY OSTEOPOROSIS SUPPORTIVE ONCOLOGY CARE

Clinical Oncology News

Topical Gel Relieves Painful Rash Caused by Anti-EGFR Therapies

Novel BRAF inhibitor gel reactivates disrupted MAPK signaling pathways in affected skin areas, restoring normal function while maintaining systemic anticancer therapy effectiveness.

Dermatology June 24th 2025

Tags: COLORECTAL CANCER (CRC) DISEASE COMPLICATIONS RESEARCH & CLINICAL TRIALS SKIN CONDITIONS/RASH SUPPORTIVE ONCOLOGY CARE

Trending Topics:

Articles related to SUPPORTIVE ONCOLOGY CARE

Is It Time for a New Type of Cancer Physician?

Yale Study Finds Reduced Opioid Prescribing for Some Patients with Cancer

FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab

Topical Gel Relieves Painful Rash Caused by Anti-EGFR Therapies

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form